Literature DB >> 11139617

Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.

S Jacquenet1, D Ropers, P S Bilodeau, L Damier, A Mougin, C M Stoltzfus, C Branlant.   

Abstract

The HIV-1 transcript is alternatively spliced to over 30 different mRNAs. Whether RNA secondary structure can influence HIV-1 RNA alternative splicing has not previously been examined. Here we have determined the secondary structure of the HIV-1/BRU RNA segment, containing the alternative A3, A4a, A4b, A4c and A5 3' splice sites. Site A3, required for tat mRNA production, is contained in the terminal loop of a stem-loop structure (SLS2), which is highly conserved in HIV-1 and related SIVcpz strains. The exon splicing silencer (ESS2) acting on site A3 is located in a long irregular stem-loop structure (SLS3). Two SLS3 domains were protected by nuclear components under splicing condition assays. One contains the A4c branch points and a putative SR protein binding site. The other one is adjacent to ESS2. Unexpectedly, only the 3' A residue of ESS2 was protected. The suboptimal A3 polypyrimidine tract (PPT) is base paired. Using site-directed mutagenesis and transfection of a mini-HIV-1 cDNA into HeLa cells, we found that, in a wild-type PPT context, a mutation of the A3 downstream sequence that reinforced SLS2 stability decreased site A3 utilization. This was not the case with an optimized PPT. Hence, sequence and secondary structure of the PPT may cooperate in limiting site A3 utilization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139617      PMCID: PMC29680          DOI: 10.1093/nar/29.2.464

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Secondary structure of the yeast Saccharomyces cerevisiae pre-U3A snoRNA and its implication for splicing efficiency.

Authors:  A Mougin; A Grégoire; J Banroques; V Ségault; R Fournier; F Brulé; M Chevrier-Miller; C Branlant
Journal:  RNA       Date:  1996-11       Impact factor: 4.942

2.  Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.

Authors:  Z Si; B A Amendt; C M Stoltzfus
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.

Authors:  B A Amendt; Z H Si; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

4.  Intramolecular structure in yeast introns aids the early steps of in vitro spliceosome assembly.

Authors:  B Charpentier; M Rosbash
Journal:  RNA       Date:  1996-06       Impact factor: 4.942

5.  An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.

Authors:  B Chabot; M Blanchette; I Lapierre; H La Branche
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

6.  The D1-A2 and D2-A2 pairs of splice sites from human immunodeficiency virus type 1 are highly efficient in vitro, in spite of an unusual branch site.

Authors:  L Damier; L Domenjoud; C Branlant
Journal:  Biochem Biophys Res Commun       Date:  1997-08-08       Impact factor: 3.575

7.  A specific RNA hairpin loop structure binds the RNA recognition motifs of the Drosophila SR protein B52.

Authors:  H Shi; B E Hoffman; J T Lis
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

8.  16S-23S and 23S-5S intergenic spacer regions of Streptococcus thermophilus and Streptococcus salivarius, primary and secondary structure.

Authors:  M Nour; A Naimi; G Beck; C Branlant
Journal:  Curr Microbiol       Date:  1995-11       Impact factor: 2.188

Review 9.  HIV-1: fifteen proteins and an RNA.

Authors:  A D Frankel; J A Young
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.

Authors:  M M O'Reilly; M T McNally; K L Beemon
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

View more
  41 in total

1.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.

Authors:  Dibyakanti Mandal; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor.

Authors:  Javier Cabello-Villegas; Keith E Giles; Ana Maria Soto; Ping Yu; Annie Mougin; Karen L Beemon; Yun-Xing Wang
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

Review 4.  Influence of RNA secondary structure on the pre-mRNA splicing process.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

5.  Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.

Authors:  Masako Nomaguchi; Naoya Doi; Yosuke Sakai; Hirotaka Ode; Yasumasa Iwatani; Takamasa Ueno; Yui Matsumoto; Yasuyuki Miyazaki; Takao Masuda; Akio Adachi
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  The secondary structure of the human immunodeficiency virus type 1 transcript modulates viral splicing and infectivity.

Authors:  Joseph A Jablonski; Emanuele Buratti; Cristiana Stuani; Massimo Caputi
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

7.  Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin.

Authors:  F Nicoletti; C Lapenta; C Lamenta; S Donati; M Spada; A Ranazzi; B Cacopardo; K Mangano; F Belardelli; C Perno; S Aquaro
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation.

Authors:  Xinjun Zhang; Hai Lin; Huiying Zhao; Yangyang Hao; Matthew Mort; David N Cooper; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

Review 9.  Role of RNA structure in regulating pre-mRNA splicing.

Authors:  M Bryan Warf; J Andrew Berglund
Journal:  Trends Biochem Sci       Date:  2009-12-01       Impact factor: 13.807

Review 10.  Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences.

Authors:  Nobubelo K Ngandu; Konrad Scheffler; Penny Moore; Zenda Woodman; Darren Martin; Cathal Seoighe
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.